ArticleFrontiers in public health2026
Development of peribronchiolar fibrosis is associated with local immune and MAPK pathway activation in a murine model of deployment-related constrictive bronchiolitis.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aim: Deployment-related constrictive bronchiolitis (DRCB), a chronic fibrotic small airway disease, has been reported in military personnel following deployment to Southwest Asia and Afghanistan. Veterans diagnosed with DRCB indicate exposure to inhalational hazards, yet the molecular pathophysiology of this disorder remains enigmatic. Club cells are local progenitors critical for repair of small airway epithelium after inhalational injury. We have previously modeled DRCB using transgenic CC-DTA mice in which sustained club cell injury induces murine constrictive bronchiolitis (mCB) that recapitulates many of the histopathologic abnormalities observed in DRCB including peribronchiolar inflammation and fibrosis. The aim of the current study was to identify molecular pathways activated at the site of injury during the development of mCB. Methods: CC-DTA and control mice were exposed to doxycycline on protocol day 0-10 to induce club cell injury. Protein digital spatial profiling restricted to small airways was performed on lung sections harvested on protocol day 0, 10, and 20 and targeted a panel of 57 proteins focused on immune modulation and MAPK signaling. Results: Sustained club cell injury mediated small airway wall thickening due to enhanced deposition of subepithelial collagen fibers. Principal component analysis separated small airways of CC-DTA from control mice on day 10 and 20. Upregulated protein expression in small airways of CC-DTA versus control mice was found to be most numerous and prominent on day 20 and included an array of proteins involved in myeloid or lymphoid cell activation, signal transduction in response to extracellular stress stimuli, and regulation of cell proliferation, differentiation and survival. Immunofluorescence validated an increase in programmed death-ligand 1 Conclusion: We identified features of chronic innate and adaptive immune activation and aberrant collagen deposition within injured small airways during the development of mCB. Further, our findings implicate the PD-1/PD-L1 axis and the MAPK/ERK pathway in the pathogenesis of DRCB and may reveal potential therapeutic targets for combating this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.